| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | 10% Owner
4 companies
New Enterprise Associates 16, L.P. is a 10% Owner at TRVI, with reported holdings spanning 4 companies. Recent filings cover 7 purchases and 2 sales. Those positions are worth an estimated $25.0M at current prices.
Our model assigns New Enterprise Associates 16, L.P. a below-average insider score of 36/100, based on 4 past trades. Over a 12-month horizon, 25.0% of those trades were profitable, with an average 12-month return of -27.1%.
New Enterprise Associates 16, L.P.'s largest disclosed position is in TRVI as 10% Owner, worth about $19.8M. Net of sales, the recent Form 4 record there shows accumulation of 6,982,866 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 2025 | NEUE Neuehealth, Inc. | Director, 10% Owner | Sale+OE | 280 | $6.75 | $1,890.00 | - | - | - | |
| Dec 23, 2024 | MRKR Marker Therapeutics, Inc. | 10% Owner | Buy | 554,250 | $3.20 | $1,773,600.00 | +51.7% | -62.6% | -60.5% | |
| Apr 11, 2022 | TRVI Trevi Therapeutics, Inc. | 10% Owner | Buy | 2,631,578 | $1.90 | $4,999,998.20 | +33.8% | +31.2% | -32.7% | |
| Oct 18, 2021 | TRVI Trevi Therapeutics, Inc. | 10% Owner | Buy | 1,851,852 | $0.00 | - | +31.2% | -40.8% | +62.7% | |
| Mar 16, 2021 | MRKR Marker Therapeutics, Inc. | 10% Owner | Buy | 5,714,285 | $1.75 | $9,999,998.75 | +114.3% | +91.4% | -77.7% | |
| Apr 3, 2020 | TRVI Trevi Therapeutics, Inc. | 10% Owner | Sell | 564 | $2.66 | $1,500.24 | - | - | - | |
| Jul 22, 2019 | MIRM Mirum Pharmaceuticals, Inc. | 10% Owner | Buy | 450,000 | $15.00 | $6,750,000.00 | +12.0% | - | - | |
| May 9, 2019 | TRVI Trevi Therapeutics, Inc. | 10% Owner | Buy | 2,500,000 | $10.00 | $25,000,000.00 | +129.0% | - | - |